The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021)

KE Hanson, AM Caliendo, CA Arias… - Clinical infectious …, 2024 - academic.oup.com
Background Accurate molecular diagnostic tests are necessary for confirming a diagnosis of
coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory …

[HTML][HTML] Crisis management, transnational healthcare challenges and opportunities: The intersection of COVID-19 pandemic and global mental health

J Abbas - Research in Globalization, 2021 - Elsevier
The existing literature has paid insufficient attention to crisis management of global health
challenges in the advent of epidemics and pandemics. This study articulates resilience …

Covid-19 image data collection: Prospective predictions are the future

JP Cohen, P Morrison, L Dao, K Roth… - arXiv preprint arXiv …, 2020 - arxiv.org
Across the world's coronavirus disease 2019 (COVID-19) hot spots, the need to streamline
patient diagnosis and management has become more pressing than ever. As one of the …

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

RM Elshazli, EA Toraih, A Elgaml, M El-Mowafy… - PloS one, 2020 - journals.plos.org
Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

GV Soraya, ZS Ulhaq - Medicina clinica, 2020 - Elsevier
Introduction and objectives Common laboratory parameters are crucial in aiding coronavirus
disease 2019 (COVID-19) case detection. This study aimed to determine the differences …

[HTML][HTML] Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients

YL Lee, CH Liao, PY Liu, CY Cheng… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Liu et al. in this Journal recently reported a COVID-19 patient with prolonged viral shedding
even after seroconversion. 1 The patient's antibody to SARS-CoV-2 viral nucleocapsid (N) …

Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis

R Tariq, S Saha, F Furqan, L Hassett, D Pardi… - Mayo Clinic …, 2020 - Elsevier
Objective To perform a systematic review and meta-analysis evaluating the prevalence of
gastrointestinal (GI) symptoms and mortality in patients with coronavirus disease 2019 …

[HTML][HTML] Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis

A Baradaran, MH Ebrahimzadeh… - Archives of Bone and …, 2020 - ncbi.nlm.nih.gov
Background: In this study, we aimed to assess the prevalence of comorbidities in the
confirmed COVID-19 patients. This might help showing which comorbidity might pose the …

COVID-19 vaccines: concerns beyond protective efficacy and safety

CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …

Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and …

M Shehab, F Alrashed, S Shuaibi… - BMJ open …, 2021 - bmjopengastro.bmj.com
Background and aims Patients infected with the SARS-CoV-2 usually report fever and
respiratory symptoms. However, multiple gastrointestinal (GI) manifestations such as …